204 related articles for article (PubMed ID: 30048317)
1. The Influence of Antireflux Surgery on Esophageal Cancer Risk in England: National Population-based Cohort Study.
Markar SR; Arhi C; Leusink A; Vidal-Diez A; Karthikesalingam A; Darzi A; Lagergren J; Hanna GB
Ann Surg; 2018 Nov; 268(5):861-867. PubMed ID: 30048317
[TBL] [Abstract][Full Text] [Related]
2. Long-term outcome of medical and surgical therapies for gastroesophageal reflux disease: follow-up of a randomized controlled trial.
Spechler SJ; Lee E; Ahnen D; Goyal RK; Hirano I; Ramirez F; Raufman JP; Sampliner R; Schnell T; Sontag S; Vlahcevic ZR; Young R; Williford W
JAMA; 2001 May; 285(18):2331-8. PubMed ID: 11343480
[TBL] [Abstract][Full Text] [Related]
3. Esophageal Adenocarcinoma After Antireflux Surgery in a Cohort Study From the 5 Nordic Countries.
Maret-Ouda J; Santoni G; Wahlin K; Artama M; Brusselaers N; Färkkilä M; Lynge E; Mattsson F; Pukkala E; Romundstad P; Tryggvadóttir L; von Euler-Chelpin M; Lagergren J
Ann Surg; 2021 Dec; 274(6):e535-e540. PubMed ID: 31800492
[TBL] [Abstract][Full Text] [Related]
4. Risk of Esophageal Adenocarcinoma After Antireflux Surgery in Patients With Gastroesophageal Reflux Disease in the Nordic Countries.
Maret-Ouda J; Wahlin K; Artama M; Brusselaers N; Färkkilä M; Lynge E; Mattsson F; Pukkala E; Romundstad P; Tryggvadóttir L; von Euler-Chelpin M; Lagergren J
JAMA Oncol; 2018 Nov; 4(11):1576-1582. PubMed ID: 30422249
[TBL] [Abstract][Full Text] [Related]
5. Esophageal adenocarcinoma arising after antireflux surgery: a population-based analysis.
Kauttu TM; Rantanen TK; Sihvo EI; Räsänen JV; Puolakkainen P; Salo JA
Eur J Cardiothorac Surg; 2011 Dec; 40(6):1450-4; discussion 1454. PubMed ID: 21546258
[TBL] [Abstract][Full Text] [Related]
6. Antireflux Surgery and Risk of Esophageal Adenocarcinoma: A Systematic Review and Meta-analysis.
Maret-Ouda J; Konings P; Lagergren J; Brusselaers N
Ann Surg; 2016 Feb; 263(2):251-7. PubMed ID: 26501714
[TBL] [Abstract][Full Text] [Related]
7. Gastroesophageal reflux, barrett esophagus, and esophageal cancer: scientific review.
Shaheen N; Ransohoff DF
JAMA; 2002 Apr; 287(15):1972-81. PubMed ID: 11960540
[TBL] [Abstract][Full Text] [Related]
8. Is esophageal adenocarcinoma occurring late after antireflux surgery due to persistent postoperative reflux?
Lagergren J; Viklund P
World J Surg; 2007 Mar; 31(3):465-9. PubMed ID: 17171490
[TBL] [Abstract][Full Text] [Related]
9. [Comparison of surgical patients with gastroesophageal reflux disease and Barrett's esophagus].
Zsolt S; Paszt A; Géczi T; Abrahám S; Tóth I; Horváth Z; Pieler J; Tajti J; Varga A; Tiszlavicz L; Németh I; Izbéki F; Rosztóczy A; Wittmann T; Lázár G
Magy Seb; 2014 Oct; 67(5):287-96. PubMed ID: 25327403
[TBL] [Abstract][Full Text] [Related]
10. Reintervention After Antireflux Surgery for Gastroesophageal Reflux Disease in England.
Markar SR; Arhi C; Wiggins T; Vidal-Diez A; Karthikesalingam A; Darzi A; Lagergren J; Hanna GB
Ann Surg; 2020 Apr; 271(4):709-715. PubMed ID: 30499807
[TBL] [Abstract][Full Text] [Related]
11. Laparoscopic antireflux surgery in the treatment of gastroesophageal reflux in patients with Barrett esophagus.
Yau P; Watson DI; Devitt PG; Game PA; Jamieson GG
Arch Surg; 2000 Jul; 135(7):801-5. PubMed ID: 10896373
[TBL] [Abstract][Full Text] [Related]
12. Antireflux Surgery Versus Antireflux Medication and Risk of Esophageal Adenocarcinoma in Patients With Barrett's Esophagus.
Åkerström JH; Santoni G; von Euler Chelpin M; Ness-Jensen E; Kauppila JH; Holmberg D; Lagergren J
Gastroenterology; 2024 Jan; 166(1):132-138.e3. PubMed ID: 37690771
[TBL] [Abstract][Full Text] [Related]
13. LOW PREVALENCE OF BARRETT'S ESOPHAGUS IN A RISK AREA FOR ESOPHAGEAL CANCER IN SOUTH OF BRAZIL.
DE Carli DM; Araujo AF; Fagundes RB
Arq Gastroenterol; 2017 Dec; 54(4):305-307. PubMed ID: 28954045
[TBL] [Abstract][Full Text] [Related]
14. Metabolic syndrome and risk of esophageal adenocarcinoma in elderly patients in the United States: An analysis of SEER-Medicare data.
Drahos J; Ricker W; Pfeiffer RM; Cook MB
Cancer; 2017 Feb; 123(4):657-665. PubMed ID: 27861759
[TBL] [Abstract][Full Text] [Related]
15. Reflux control is important in the management of Barrett's Esophagus: results from a retrospective 1,830 patient cohort.
Brown CS; Lapin B; Wang C; Goldstein JL; Linn JG; Denham W; Haggerty SP; Talamonti MS; Howington JA; Carbray J; Ujiki MB
Surg Endosc; 2015 Dec; 29(12):3528-34. PubMed ID: 25676204
[TBL] [Abstract][Full Text] [Related]
16. Gastroesophageal Reflux Frequency, Severity, Age of Onset, Family History and Acid Suppressive Therapy Predict Barrett Esophagus in a Large Population.
Bakr O; Zhao W; Corley D
J Clin Gastroenterol; 2018; 52(10):873-879. PubMed ID: 29356784
[TBL] [Abstract][Full Text] [Related]
17. Does a surgical antireflux procedure decrease the incidence of esophageal adenocarcinoma in Barrett's esophagus? A meta-analysis.
Corey KE; Schmitz SM; Shaheen NJ
Am J Gastroenterol; 2003 Nov; 98(11):2390-4. PubMed ID: 14638338
[TBL] [Abstract][Full Text] [Related]
18. Risk factors for esophageal adenocarcinoma after antireflux surgery.
Löfdahl HE; Lu Y; Lagergren P; Lagergren J
Ann Surg; 2013 Apr; 257(4):579-82. PubMed ID: 23426349
[TBL] [Abstract][Full Text] [Related]
19. Differential response to preoperative chemoradiation and surgery in esophageal adenocarcinomas based on presence of Barrett's esophagus and symptomatic gastroesophageal reflux.
Agarwal B; Swisher SG; Ajani J; Kelly K; Komaki RR; Abu-Hamda E; Correa AM; Roth JA
Ann Thorac Surg; 2005 May; 79(5):1716-23. PubMed ID: 15854962
[TBL] [Abstract][Full Text] [Related]
20. Antireflux Surgery and Barrett's Esophagus: Myth or Reality?
Herbella FAM; Schlottmann F; Patti MG
World J Surg; 2018 Jun; 42(6):1798-1802. PubMed ID: 29264726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]